Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Fortrea appoints Agnieszka Gallagher as general counsel
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 71190, member: 636"] Fortrea appointed Agnieszka Gallagher as general counsel to succeed Stillman Hanson, who departed after completing a planned transition period at the Durham, North Carolina, contract research organization. Chief executive Anshul Thakral stated that Gallagher brings extensive life sciences leadership experience and a proven ability to align legal strategy with business objectives while managing complex global operations. Gallagher previously served as chief legal officer at Standard BioTools and held senior legal positions at OraSure Technology, Alnylam Pharmaceuticals, ViiV Healthcare, GSK, Sandoz, Medtronic and Pfizer. She will oversee legal strategy, compliance operations and corporate governance while serving as corporate secretary for the clinical development services provider. Hanson spent approximately two and a half years at Fortrea following previous roles at G1 Therapeutics, IQVIA and Quintiles Transnational Holdings before entering private legal practice at Smith Anderson. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Fortrea appoints Agnieszka Gallagher as general counsel
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top